Abstract
Accurate disease diagnosis, patient stratification and biomarker validation require the analysis of multiple biomarkers. This paper describes cross-reactivity-free multiplexing of enzyme-linked immunosorbent assays (ELISAs) using aqueous two-phase systems (ATPSs) to confine detection antibodies at specific locations in fully aqueous environments. Antibody cross-reactions are eliminated because the detection antibody solutions are co-localized only to corresponding surface-immobilized capture antibody spots. This multiplexing technique is validated using plasma samples from allogeneic bone marrow recipients. Patients with acute graft versus host disease (GVHD), a common and serious condition associated with allogeneic bone marrow transplantation, display higher mean concentrations for four multiplexed biomarkers (HGF, elafin, ST2 and TNFR1) relative to healthy donors and transplant patients without GVHD. The antibody co-localization capability of this technology is particularly useful when using inherently cross-reactive reagents such as polyclonal antibodies, although monoclonal antibody cross-reactivity can also be reduced. Because ATPS-ELISA adapts readily available antibody reagents, plate materials and detection instruments, it should be easily transferable into other research and clinical settings.
Original language | English |
---|---|
Article number | 4878 |
Journal | Scientific Reports |
Volume | 4 |
DOIs | |
Publication status | Published - May 2 2014 |
Externally published | Yes |
Bibliographical note
Funding Information:The authors wish to acknowledge funding from the following agencies: ST Coulter Foundation & NSF IIP1243080; SP National Institutes of Health grant RC1HL101102, Eric Hartwell Research fund and the Amy Strelzer Manasevit Research Program; JBW NSF DGE 0718128 (ID: 2010101926).
ASJC Scopus Subject Areas
- General
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.